Tiludronic acid

Tiludronic acid

Systematic (IUPAC) name
{[(4-chlorophenyl)thio]methylene}bis(phosphonic acid)
Clinical data
AHFS/Drugs.com	International Drug Names
Pregnancy cat.	?
Legal status	?
Identifiers
CAS number	89987-06-4^Y
ATC code	M05BA05
PubChem	CID 60937
DrugBank	APRD01259
UNII	6PNS59HP4Y^N
KEGG	D08599^N
ChEMBL	CHEMBL1350^N
Chemical data
Formula	C₇H₉Cl O₆P₂S
Mol. mass	318.609 g/mol
N(what is this?) (verify)

Tiludronic acid (INN; also known as tiludronate) is a bisphosphonate. It has the tradename Skelid.

Administration

Tiludronic acid is administered orally. The recommended dose is a single 400-mg daily oral dose, taken with 6 to 8 ounces of plain water only, should be administered for a period of 3 months. Beverages other than plain water (including mineral water), food (see below), and some medications are likely to reduce the tiludronic acid's absorption.

External links

Drugs for treatment of bone diseases (M05)

Bisphosphonates

Nitrogenous (Alendronic acid, ibandronic acid, incadronic acid, pamidronic acid, risedronic acid, zoledronic acid)
Non-nitrogenous (Etidronic acid, clodronic acid, tiludronic acid)

Bone morphogenetic proteins

Dibotermin alfa • Eptotermin alfa

Other

Resorption inhibitor (Ipriflavone) • Aluminium chlorohydrate • Dual action bone agent (Strontium ranelate) •
RANKL inhibitor (Denosumab) • Cathepsin K inhibitor (Odanacatib)

M: BON/CAR

anat(c/f/k/f, u, t/p, l)/phys/devp/cell

noco/cong/tumr, sysi/epon, injr

proc, drug(M5)